Results 81 to 90 of about 756 (179)

Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone [PDF]

, 2015
Eldecalcitol (ELD), an active form of vitamin D analog approved for the treatment of osteoporosis in Japan, increases lumbar spine bone mineral density (BMD), suppresses bone turnover markers, and reduces fracture risk in patients with osteoporosis.We ...
Amizuka, N., Hasegawa, T., Saito H., Burr, DB., Grynpas, MD., Allen, MR., Kida, Y., Smith, SY., Marumo, K., Saito, M., Doyle, N.   +10 more
core   +1 more source

High frequency:Low frequency ratios over time.

, 2015
(A) capecitabine, (B) eldecalcitol, (C) epoetin beta pegol, (D) peginterferon alfa-2a, and (E) sevelamer hydrochloride.
Seigo Okugawa (733308), Kotonari Aoki (733302), Terumi Nakayama (733307), Takumi Kobayashi (733305), Takuya Kawamata (733303), Minami Tomita (733310), Yoshihiko Sugimura (733309), Yoichiro Takahashi (733311), Hiroshi Kuriki (733306), Shinichi Matsuda (733301), Tetsuji Kimotsuki (733304)   +10 more
core   +1 more source

Zinc improves Denosumab and eldecalcitol efficacy for bone mineral density in patients with hypozincemia

Introduction We aimed to investigate the effects of zinc deficiency and zinc medication in osteoporosis patients undergoing denosumab (DMAb). Materials and methods This retrospective study was conducted at a single hospital.
Kanayama, Masahiro, Shimizu, Tomohiro, Oha, Fumihiro, Ishizu, Hotaka, Ohashi, Yusuke, Iwasaki, Norimasa, Kusunoki, Kenichi   +6 more
core   +1 more source

Adverse drug reaction reporting trend for 5 drugs.

, 2015
Total number of individual case safety reports for (A) capecitabine, (B) eldecalcitol, (C) epoetin beta pegol, (D) peginterferon alfa-2a, and (E) sevelamer hydrochloride.
Seigo Okugawa (733308), Kotonari Aoki (733302), Terumi Nakayama (733307), Takumi Kobayashi (733305), Takuya Kawamata (733303), Minami Tomita (733310), Yoshihiko Sugimura (733309), Yoichiro Takahashi (733311), Hiroshi Kuriki (733306), Shinichi Matsuda (733301), Tetsuji Kimotsuki (733304)   +10 more
core   +1 more source

Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats [PDF]

, 2015
Bisphosphonates are widely used in the treatment of osteoporosis and contribute to the reduction of bone fractures. Ibandronate (IBN) is a highly potent, nitrogen-containing bisphosphonate, which is administered orally or intravenously at extended dosing
Sakai, Sadaoki, Endo, Koichi, Shimonaka, Yasushi, Yogo, Kenji, Takeda, Satoshi, Bauss, Frieder, Shimizu, Masaru, Hashimoto, Junko, Sugimoto, Masanori   +8 more
core   +1 more source

Eldecalcitol is more effective for promoting osteogenesis than alfacalcidol in Cyp27b1-knockout Mice

, 2018
Calcium (Ca) absorption from the intestinal tract is promoted by active vitamin D (1α,25D3). Vitamin D not only promotes Ca homeostasis, but it also inhibits bone resorption and promotes osteogenesis, thus playing a role in the maintenance of normal bone
Keigo Isomoto, Yoshitomo Suhara, Yoshihisa Hirota, Toshiyuki Sakaki, Kimie Nakagawa, Noboru Kubodera, Maya Kamao, Toshio Okano, Naomi Osakabe   +8 more
core   +1 more source

A Health Technology Assessment Based on Chinese Guideline: Active Vitamin D and Its Analogs in the Treatment of Osteoporosis

Drug Design, Development and Therapy
Siyong Huang, Jiabao Li, Xiao Hu, Jisheng Chen Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, People’s Republic of ChinaCorrespondence: Jisheng Chen, Key Specialty of Clinical Pharmacy,
Huang S, Li J, Hu X, Chen J
doaj  

Combination treatment with ibandronate and eldecalcitol prevents osteoporotic bone loss and deterioration of bone quality characterized by nano-arrangement of the collagen/apatite in an ovariectomized aged rat model [PDF]

Ozasa R., Saito M., Ishimoto T., et al. Combination treatment with ibandronate and eldecalcitol prevents osteoporotic bone loss and deterioration of bone quality characterized by nano-arrangement of the collagen/apatite in an ovariectomized aged rat ...
Saito, Mitsuru, Ishimoto, Takuya, Nakano, Takayoshi, Ozasa, Ryosuke, Matsumoto, Yoshihiro, Matsugaki, Aira   +5 more
core   +1 more source

Risperidone induces osteoporosis and neuropsychiatric treatment resistance via SMPD1-lysosome-mediated ferroptosis: dual rescue by active vitamin D analog ED-71

Journal of Advanced Research
Introduction: Risperidone (RIS), a second-generation antipsychotic for schizophrenia (SZ), is linked to osteoporosis and suboptimal symptom resolution. The shared cellular mechanisms underlying these cross-tissue toxicities (bone and hippocampus) remain ...
Yajun Cui, Ke Ma, Lingshuang Li, Xuejie Lin, Yu Ji, Haipeng Si, Hongrui Liu, Minqi Li   +7 more
doaj   +1 more source

Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT. [PDF]

, 2011
The effects of an active vitamin D analog, eldecalcitol (ELD), on bone mineral density (BMD), bone geometry, and biomechanical properties of the proximal femur were investigated by using clinical CT.
Masako Ito, Toshitaka Nakamura, Shiraki, Masataka, Nakamura, Toshitaka, Masao Fukunaga, Masataka Shiraki, Fukunaga, Masao, Matsumoto, Toshio, Ito, Masako, Toshio Matsumoto   +9 more
core   +1 more source